‘Reborn’ Cincinnati seeks deeper relationship with Israel, will attend MIXiii
May. 14, 2014
A group of 40 top business and civic officials from the Greater Cincinnati area expect to be in Israel next week to promote the city as a place for Israeli companies to do business. Like other suitors of Israeli start-ups and established firms, the Cincinnati delegation are set to inform Israeli firms of the advantages of setting up sales offices, research centers and headquarters in the United States.
Like the other US states and cities seeking Israeli business, members of the delegation will proclaim their region as one of diversified business activity, good investment potential and home to a dynamic, entrepreneurial vibe that suits Israeli companies.
The REDI delegation includes executives from companies in various sectors, including hi-tech and biomed firms and capital funds. Members of the delegation include top Cincinnati business officials, such as Tim Schigel, CEO of Cintrifuse Fund of Funds; Glen Mayfield, founder and CEO of River Cities Capital Funds; Ken Phelps, president and CEO of Camargo Pharmaceutical Services; Steve L. Rosedale, founder and CEO of CommuniCare Health Services; Jim Stagge, senior director of business development at CTI Clinical Trial and Consulting Services; and Dr. Candace Gunnarsson, vice president of CTI Clinical Trial & Consulting.
Members of the delegation will attend the upcoming MIXiii Israel Innovation Conference, the premier Israeli tech event of the year, on May 20 through 22. They have meetings set with Israeli companies in industries such as 3D printing, data intelligence and big data, cyber security, consumer tech, fintec, connected devices and wearable tech, medical devices and pharma-development.
For the full story on Start-Up Israel click here.